Abstract Title:

Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants.

Abstract Source:

Chin Med. 2008 Mar 29;3:4. PMID: 10802503

Abstract Author(s):

G V Stajich, G P Lopez, S W Harry, W R Sexson

Article Affiliation:

Mercer University, Southern School of Pharmacy, Atlanta, Georgia 30341, USA.

Abstract:

Thimerosal, a derivative of mercury, is used as a preservative in hepatitis B vaccines. We measured total mercury levels before and after the administration of this vaccine in 15 preterm and 5 term infants. Comparison of pre- and post-vaccination mercury levels showed a significant increase in both preterm and term infants after vaccination. Additionally, post-vaccination mercury levels were significantly higher in preterm infants as compared with term infants. Because mercury is known to be a potential neurotoxin to infants, further study of its pharmacodynamics is warranted.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.